| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $403,862 | 12 | 100 |
| Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | 0 | $0 | 3 | $38,789 | $-38,789 |
| Florin Daniel P | director | 0 | $0 | 1 | $46,409 | $-46,409 |
| Radhakrishnan Srikanth | Chief Science &Techn. Officer | 0 | $0 | 2 | $47,184 | $-47,184 |
| Lehman David Aaron | GENERAL COUNSEL | 0 | $0 | 3 | $66,030 | $-66,030 |
| French Glendon E. III | President and CEO | 0 | $0 | 3 | $205,450 | $-205,450 |
Pulmonx Corporation is a biomedical technology firm dedicated to developing and commercializing advanced, less invasive devices for managing chronic obstructive pulmonary diseases. Its primary offering, the Zephyr Endobronchial Valve, is specifically engineered to treat bronchoscopic hyperinflation in adults afflicted with severe emphysema. Complementing its therapeutic solutions, the company also provides the Chartis Pulmonary Assessment System. This system features a specialized balloon catheter and console, fitted with flow and pressure …
Over the last 12 months, insiders at Pulmonx Corporation have bought $0 and sold $403,862 worth of Pulmonx Corporation stock.
On average, over the past 5 years, insiders at Pulmonx Corporation have bought $69,189 and sold $1.91M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 23,321 shares for transaction amount of $71,362 was made by Florin Daniel P (director) on 2025‑06‑05.
| 2026-09-01 | Sale | French Glendon E. III | President and CEO | 41,882 0.1% | $2.26 | $94,653 | -14.73% | |
| 2026-09-01 | Sale | Rose Geoffrey Beran | Chief Commercial Officer | 7,879 0.0188% | $2.26 | $17,807 | -14.73% | |
| 2026-09-01 | Sale | Lehman David Aaron | General Counsel | 14,334 0.0342% | $2.26 | $32,395 | -14.73% | |
| 2026-09-01 | Sale | Radhakrishnan Srikanth | Chief Science & Techn. Officer | 14,245 0.034% | $2.26 | $32,194 | -14.73% | |
| 2026-03-02 | Sale | French Glendon E. III | President and CEO | 67,813 0.1488% | $1.43 | $96,973 | +0.65% | |
| 2026-03-02 | Sale | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | 7,732 0.017% | $1.43 | $11,057 | +0.65% | |
| 2026-03-02 | Sale | Lehman David Aaron | GENERAL COUNSEL | 12,237 0.0269% | $1.43 | $17,499 | +0.65% | |
| 2026-03-02 | Sale | Radhakrishnan Srikanth | Chief Science &Techn. Officer | 10,483 0.023% | $1.43 | $14,991 | +0.65% | |
| 2025-12-08 | Sale | Florin Daniel P | director | 23,321 0.0552% | $1.99 | $46,409 | -20.10% | |
| 2025-12-01 | Sale | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | 6,322 0.0137% | $1.57 | $9,926 | -7.10% | |
| 2025-12-01 | Sale | French Glendon E. III | President and CEO | 8,805 0.019% | $1.57 | $13,824 | -7.10% | |
| 2025-12-01 | Sale | Lehman David Aaron | GENERAL COUNSEL | 10,278 0.0222% | $1.57 | $16,136 | -7.10% | |
| 2025-09-02 | Sale | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | 6,543 0.0149% | $1.60 | $10,469 | -7.51% | |
| 2025-09-02 | Sale | Williamson Steven S. | PRESIDENT AND CEO | 9,648 0.0219% | $1.60 | $15,437 | -7.51% | |
| 2025-09-02 | Sale | Lehman David Aaron | GENERAL COUNSEL | 929 0.0021% | $1.60 | $1,486 | -7.51% | |
| 2025-09-02 | Sale | Lehman David Aaron | GENERAL COUNSEL | 9,769 0.0222% | $1.60 | $15,630 | -7.51% | |
| 2025-09-02 | Sale | Joshi Mehul | Chief Financial Officer & PAO | 7,936 0.018% | $1.60 | $12,698 | -7.51% | |
| 2025-06-12 | Sale | Ferrari Richard | director | 8,000 0.02% | $3.16 | $25,280 | -47.77% | |
| 2025-06-05 | Florin Daniel P | director | 23,321 0.0597% | $3.06 | $71,362 | -44.11% | ||
| 2025-06-02 | Sale | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | 6,947 0.0173% | $3.13 | $21,748 | -46.33% |
| Florin Daniel P | director | 93910 0.2187% | $255,435.20 | 4 | 1 | <0.0001% |
| Williamson Steven S. | PRESIDENT AND CEO | 358967 0.8358% | $976,390.24 | 1 | 3 | <0.0001% |
| Ferrari Richard | director | 87024 0.2026% | $236,705.28 | 3 | 1 | +64.56% |
| Mead Dana G Jr. | director | 26315 0.0613% | $71,576.80 | 1 | 0 | <0.0001% |
| Melenikiotou Georgia | director | 26315 0.0613% | $71,576.80 | 1 | 0 | <0.0001% |
| Lynch Alissa Hsu | director | 11910 0.0277% | $32,395.20 | 1 | 0 | +102.06% |
| Increased Positions | 53 | +37.59% | 8M | +25.8% |
| Decreased Positions | 60 | -42.55% | 6M | -19.12% |
| New Positions | 25 | New | 6M | New |
| Sold Out Positions | 22 | Sold Out | 1M | Sold Out |
| Total Postitions | 134 | -4.96% | 33M | +6.69% |
| Primecap Management Co/Ca/ | $11,400.00 | 12.09% | 4.96M | -207,990 | -4.03% | 2025-09-30 |
| Morgan Stanley | $8,328.00 | 8.83% | 3.62M | +63,628 | +1.79% | 2025-09-30 |
| Blackrock, Inc. | $6,152.00 | 6.52% | 2.67M | -15,977 | -0.59% | 2025-09-30 |
| Vanguard Group Inc | $5,157.00 | 5.47% | 2.24M | -51,801 | -2.26% | 2025-09-30 |
| Fmr Llc | $5,001.00 | 5.3% | 2.17M | -2M | -48.98% | 2025-09-30 |
| Silvercrest Asset Management Group Llc | $2,908.00 | 3.08% | 1.26M | +333,676 | +35.86% | 2025-09-30 |
| Deutsche Bank Ag | $2,589.00 | 2.75% | 1.13M | 0 | 0% | 2025-09-30 |
| Geode Capital Management, Llc | $2,251.00 | 2.39% | 978,762 | +49,365 | +5.31% | 2025-09-30 |
| Kent Lake Pr Llc | $2,130.00 | 2.26% | 926,157 | +926,157 | New | 2025-09-30 |
| Vestal Point Capital, Lp | $1,909.00 | 2.02% | 830,000 | +830,000 | New | 2025-09-30 |